Immunic (IMUX) Stock Research

Today

Immunic reports Q2 EPS (80c), consensus ($1.16)

IMUX

6:33 AM

Over a week ago

Immunic CEO Daniel Vitt to step down, Erik Lundgren to succeed

IMUX

May 27, 6:33 AM

B. Riley cuts Immunic target, sees 'compelling entry point'

IMUX

May 22, 9:02 AM

Immunic appoints Michael Bonney as chair

May 19, 6:33 AM

Immunic price target lowered by $7 at Roth Capital, here's why

IMUX

May 14, 8:51 AM

Immunic reports Q1 EPS ($1.08), consensus (96c)

IMUX

May 13, 6:38 AM

Immunic initiated with bullish view at LifeSci Capital

IMUX

May 4, 7:33 AM

Immunic price target adjusted to $22 from $5 at H.C. Wainwright

IMUX

Apr 30, 6:05 AM

Immunic CMO Andreas Muehler to depart, Michael Panzara to succeed

IMUX

Apr 28, 6:50 AM

Immunic trading halted, news pending

IMUX

Apr 24, 7:50 PM

Immunic announces 1-for-10 reverse stock split

IMUX

Apr 23, 8:05 AM

Immunic initiated with bullish view at Stifel, here's why

IMUX

Apr 16, 4:19 PM

Immunic just downgraded at D. Boral Capital, here's why

IMUX

Apr 15, 7:21 AM

Immunic files to sell 458.15M shares of common stock for holders

IMUX

Apr 2, 4:33 PM

Immunic regains compliance with Nasdaq

IMUX

Apr 1, 6:38 AM

Immunic appoints Mineralys Therapeutics CEO Jon Congleton to board

Mar 31, 7:03 AM

Immunic initiated with bullish view at Guggenheim, here's why

IMUX

Mar 24, 5:07 AM

Immunic gets European patent for vidofludimus calcium

IMUX

Mar 10, 6:42 AM

Immunic price target lowered by $3 at H.C. Wainwright, here's why

IMUX

Mar 2, 6:20 AM

Immunic price target lowered by $2 at H.C. Wainwright, here's why

IMUX

Nov 14, 6:13 AM

Immunic reports Q3 EPS (13c), consensus (18c)

IMUX

Nov 13, 6:33 AM

Datadog, Trade Desk upgraded: Wall Street's top analyst calls

+11

Nov 7, 9:33 AM

Immunic initiated with bullish view at Roth Capital, here's why

IMUX

Nov 7, 4:28 AM

Immunic initiated with bullish view at Ladenburg

IMUX

Oct 16, 12:16 PM

Immunic management to meet with B. Riley

IMUX

Oct 15, 4:55 AM